UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

Not Applicable

Terminated

Conditions: Hepatocellular Carcinoma
Intrahepatic Cholangiocarcinoma
Stage IV Liver Cancer
Stage IVA Liver Cancer
Stage IVB Liver Cancer
Vascular Thrombosis

Interventions: Procedure: Computed Tomography
Procedure: Single Photon Emission Computed Tomography
Drug: Technetium Tc-99m Sulfur Colloid

First Posted Date: 2016-08-29

Last Posted Date: 2025-02-14

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT02881554

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
ProCure Proton Therapy Center-Seattle, Seattle, Washington, United States

Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma

Phase 1

Completed

Conditions: Small Cell Carcinoma

Interventions: Drug: Nortriptyline Hydrochloride
Drug: Paclitaxel

First Posted Date: 2016-08-26

Last Posted Date: 2019-12-17

Lead Sponsor: University of Washington

Target Recruit Count: 2

Registration Number: NCT02881125

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Short-Term Exposure for PTSD

Not Applicable

Completed

Conditions: Marijuana Abuse
Chronic Post-Traumatic Stress Disorder

Interventions: Behavioral: Brief Imaginal Exposure

First Posted Date: 2016-08-22

Last Posted Date: 2022-08-23

Lead Sponsor: University of Washington

Target Recruit Count: 46

Registration Number: NCT02874898

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy

Phase 2

Completed

Conditions: Stage III Prostate Cancer AJCC v7
Stage IV Prostate Cancer AJCC v7
Stage III Prostate Adenocarcinoma AJCC v7
Stage IV Prostate Adenocarcinoma AJCC v7

Interventions: Drug: Abiraterone Acetate
Drug: Apalutamide
Drug: Degarelix
Drug: Indomethacin
Other: Laboratory Biomarker Analysis
Drug: Prednisone

First Posted Date: 2016-07-29

Last Posted Date: 2022-01-13

Lead Sponsor: University of Washington

Target Recruit Count: 22

Registration Number: NCT02849990

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis

Not Applicable

Active, not recruiting

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Other: Yoga

First Posted Date: 2016-07-28

Last Posted Date: 2025-01-31

Lead Sponsor: University of Washington

Target Recruit Count: 61

Registration Number: NCT02848625

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization

Completed

Conditions: Carcinoma, Hepatocellular

First Posted Date: 2016-07-28

Last Posted Date: 2018-08-02

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT02848638

Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer

Phase 1

Terminated

Conditions: ALK Gene Translocation
EGFR Activating Mutation
ROS1 Gene Translocation
Stage IV Non-Small Cell Lung Cancer AJCC v7
Recurrent Non-Small Cell Lung Carcinoma
Stage IIIB Non-Small Cell Lung Cancer AJCC v7

Interventions: Biological: Nivolumab
Drug: Plinabulin

First Posted Date: 2016-07-27

Last Posted Date: 2019-03-04

Lead Sponsor: University of Washington

Target Recruit Count: 5

Registration Number: NCT02846792

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Trial of Oral Glutamine on Mitochondrial Function in CKD

Phase 2

Completed

Conditions: Muscle Mitochondrial Function
Sarcopenia
Cardiovascular Disease
Endothelial Dysfunction
Kidney Disease

Interventions: Dietary Supplement: First Intervention (14 days)
Other: Washout (3 weeks)
Dietary Supplement: Second Intervention (14 days)

First Posted Date: 2016-07-20

Last Posted Date: 2022-07-14

Lead Sponsor: University of Washington

Target Recruit Count: 11

Registration Number: NCT02838979

Locations: 🇺🇸
Kidney Research Institute, University of Washington, Seattle, Washington, United States

Improving Medication Adherence: A Study With Talking Pill Bottles

Not Applicable

Completed

Conditions: Medication Adherence

Interventions: Other: Talking Pill Bottle

First Posted Date: 2016-07-11

Last Posted Date: 2016-07-11

Lead Sponsor: University of Washington

Target Recruit Count: 138

Registration Number: NCT02827773

Pocket Phantom Tool in Improving Accuracy of Quantitative PET/CT Imaging of Patients With Solid Tumors

Completed

Conditions: Adult Solid Neoplasm

Interventions: Procedure: Computed Tomography
Device: Imaging Phantoms
Procedure: Positron Emission Tomography

First Posted Date: 2016-07-04

Last Posted Date: 2019-09-25

Lead Sponsor: University of Washington

Target Recruit Count: 2

Registration Number: NCT02822365

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy